Anti-ERMARD monoclonal antibody

Pre-made anti-ERMARD monoclonal antibody(mab)-benchmark antibody for ELISA, affinity binding assay, drug discovery and mechanism of action (MOA) research

Target products collectionGo to ERMARD/ERMARD products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-IP0767-Ab-1/ GM-Tg-hg-IP0767-Ab-2Anti-Human ERMARD monoclonal antibodyHuman
GM-Tg-rg-IP0767-Ab-1/ GM-Tg-rg-IP0767-Ab-2Anti-Rat ERMARD monoclonal antibodyRat
GM-Tg-mg-IP0767-Ab-1/ GM-Tg-mg-IP0767-Ab-2Anti-Mouse ERMARD monoclonal antibodyMouse
GM-Tg-cynog-IP0767-Ab-1/ GM-Tg-cynog-IP0767-Ab-2Anti-Cynomolgus/ Rhesus macaque ERMARD monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-IP0767-Ab-1/ GM-Tg-felg-IP0767-Ab-2Anti-Feline ERMARD monoclonal antibodyFeline
GM-Tg-cang-IP0767-Ab-1/ GM-Tg-cang-IP0767-Ab-2Anti-Canine ERMARD monoclonal antibodyCanine
GM-Tg-bovg-IP0767-Ab-1/ GM-Tg-bovg-IP0767-Ab-2Anti-Bovine ERMARD monoclonal antibodyBovine
GM-Tg-equg-IP0767-Ab-1/ GM-Tg-equg-IP0767-Ab-2Anti-Equine ERMARD monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-IP0767-Ab-1/ GM-Tg-hg-IP0767-Ab-2; GM-Tg-rg-IP0767-Ab-1/ GM-Tg-rg-IP0767-Ab-2;
GM-Tg-mg-IP0767-Ab-1/ GM-Tg-mg-IP0767-Ab-2; GM-Tg-cynog-IP0767-Ab-1/ GM-Tg-cynog-IP0767-Ab-2;
GM-Tg-felg-IP0767-Ab-1/ GM-Tg-felg-IP0767-Ab-2; GM-Tg-cang-IP0767-Ab-1/ GM-Tg-cang-IP0767-Ab-2;
GM-Tg-bovg-IP0767-Ab-1/ GM-Tg-bovg-IP0767-Ab-2; GM-Tg-equg-IP0767-Ab-1/ GM-Tg-equg-IP0767-Ab-2
Products NameAnti-ERMARD monoclonal antibody
Formatmab
Target NameERMARD
Protein Sub-locationIntrocelluar Protein
Category of antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The potency in neutralizing, inhibiting or blocking of the target protein is not detected.
TagFc
Products descriptionPre-made anti-ERMARD monoclonal antibody(mab) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-IP0767-Ag-1Recombinant multi-species EMARD/ ERMARD/ C6orf70 protein


    Target information

    Target IDGM-IP0767
    Target NameERMARD
    Gene ID55780,361485,710978,475039,101083430,512804,100053169
    Gene Symbol and SynonymsC12H6orf70,C6orf70,C9H6orf70,CB2H6orf70,dJ266L20.3,ERMARD,PVNH6,RGD1309374,RGD1562376
    Uniprot AccessionQ5T6L9,Q3B8R1
    Uniprot Entry NameEMARD_HUMAN,EMARD_RAT
    Protein Sub-locationIntrocelluar Protein
    Category
    DiseaseN/A
    Gene EnsemblENSG00000130023
    Target ClassificationN/A

    The target: ERMARD, gene name: ERMARD, also named as C6orf70, PVNH6, dJ266L20.3. The protein encoded by this gene contains 2 transmembrane domains near the C-terminus and is localized in the endoplasmic reticulum. Knockout of this gene in developing rat brain showed that it may be involved in neuronal migration. Mutations in this gene are associated with periventricular nodular heterotopia-6 (PVNH6). Alternatively spliced transcript variants have been found for this gene. [provided by RefSeq, Dec 2013].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.